Anastomotic Time, the Incidences of Clavien-Dindo Grade II or Higher
Conditions
Brief summary
Between March 2019 and September 2022 in our centre, R anastomosis was performed on 123 patients undergoing TLDG for distal gastric cancer. A retrospective review of a prospectively collected database identified patients who underwent TLDG between January 2010 and September 2022. Patients who underwent R anastomosis were matched in a 1:1 ratio with patients who underwent conventional anastomosis using a propensity score based on age, sex, preoperative BMI, American Society of Anesthesiologists (ASA) score, and the history of abdominal surgery. Surgical and postoperative outcomes and clinicopathological data were analyzed for both groups.
Interventions
PROCEDURER anastomosis
R anastomosis
Sponsors
Daorong Wang
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
35 Years to 80 Years
Inclusion criteria
1. elective surgery for endoscopic and pathological diagnosis of malignant tumour of the gastric antrum or body with no distant metastases confirmed by multilayer spiral computed tomography; 2. patients who underwent B-II-B anastomosis during TLDG; and (3) patients who could be followed up postoperatively.
Exclusion criteria
(1) patients who had received preoperative neoadjuvant radiotherapy or chemotherapy; (2) patients undergoing emergency surgery; (3) the presence of other malignant tumours concurrently; and (4) patients who were lost to follow-up.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| the incidences of Clavien-Dindo grade II or higher | 2010-2022 | the incidences of Clavien-Dindo grade II or higher |
| anastomotic time | 2010-2022 | anastomotic time |
Countries
China
Outcome results
None listed